Cardiac injury in hospitalized patients with severe fever and thrombocytopenia syndrome

J Med Virol. 2024 Jan;96(1):e29375. doi: 10.1002/jmv.29375.

Abstract

Severe fever with thrombocytopenia syndrome (SFTS), an emerging infectious disease with a high fatality rate. Cardiac injury in SFTS patients is a major concern. This study aimed to evaluate the prevalence of cardiac injury and its association with mortality in hospitalized patients infected with novel Bunyavirus. Cardiac injury was defined as the presence of any of the following abnormalities: (1) blood levels of cardiac biomarkers (creatine kinase-MB, troponin-I, B-type natriuretic peptide or N-terminal pro-B-type natriuretic peptide); (2) new abnormalities in electrocardiography. The 203 SFTS patients were included in the final analysis. The proportion of SFTS patients developing cardiac injury during hospitalization was 71.4% (145/203). Compared with the uninjured group, the cardiac injury group had the severity of cardiac injury was underscored by higher median hospital costs (31420 vs. 12911, p < 0.001), higher proportion of intensive care units admissions (13.1% vs. 3.4%, p = 0.041), and higher hospital mortality rate (33.8% vs. 6.9%, p < 0.001). Multivariable-adjusted Cox proportional hazards regression analysis showed that cardiac injury was associated with higher mortality during hospitalization (hazards ratio, 7.349; 95% CI: 2.352-22.960). Cardiac injury is common among hospitalized SFTS patients, and it is associated with higher risk of mortality.

Keywords: cardiac injury; novel Bunyavirus; severe fever and thrombocytopenia syndrome.

MeSH terms

  • Communicable Diseases, Emerging*
  • Creatine Kinase, MB Form
  • Heart Injuries*
  • Humans
  • Natriuretic Peptide, Brain
  • Severe Fever with Thrombocytopenia Syndrome* / epidemiology
  • Thrombocytopenia* / epidemiology

Substances

  • Natriuretic Peptide, Brain
  • Creatine Kinase, MB Form